Appearance of ring sideroblasts in bone marrow during linezolid therapy

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 6-7, 2009, Pages 480-482

  Ebeling, Freja ^a   Helminen, Päivi ^b   Anttila, Veli Jukka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; LINEZOLID; METRONIDAZOLE;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW SUPPRESSION; CASE REPORT; DIALYSIS; DRUG WITHDRAWAL; ERYTHROBLAST; FEMALE; FOOT AMPUTATION; HUMAN; KIDNEY DYSFUNCTION; MYELODYSPLASTIC SYNDROME; RING SIDEROBLAST; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; WOUND INFECTION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BIOPSY, NEEDLE; BLOOD PLATELETS; BONE MARROW; ERYTHROBLASTS; ERYTHROPOIESIS; FEMALE; HUMANS; MIDDLE AGED; OXAZOLIDINONES; PLATELET COUNT;

EID: 72149121093     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540902971203     Document Type: Article

References (5)

1. French G. Safety and tolerability of linezolid. J Antimicrob Chemother 2003;/51 (Suppl 2):/45-53.
2. Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, et al. Haematological effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002;/46:/ 2723-2726
3. Monson T, Schichman SA, Zent CS. Linezolid-induced pure red blood cell aplasia. Clin Infect Dis 2002;/35:/29-31.
4. Kakimoto T, Nakazato T, Miura R, Kurai H, Yamashita D, Sagara Y, et al. Sideroblastic anaemia after prolonged linezolid therapy. Rinsho Ketsueki 2008;/49:/1566-8.
5. Lund JE, Brown PK. Hypersegmented megakaryocytes and megakaryocytes with multiple separate nuclei in dogs treated with PNU-100592, an oxazolidinone antibiotic. Toxicol Pathol 1997;/25:/339-43.